About Biopharmaceuticals sector in Singapore
The Biopharmaceuticals sector in Singapore comprises 74 companies, including 38 funded companies having collectively raised $1.62B in venture capital money and private equity. Out of these, 18 are Series A+ funded, and 1 has achieved unicorn status.
Biopharmaceuticals sector in Singapore has seen 3 acquisitions and 3 IPOs. This represents almost 8.1% of all such companies - which is higher than the 5.0% exit rate of tech companies in general.
This sector includes companies engaged in R&D for developing pharmaceuticals for the treatment of various diseases.
Companies included in Biopharmaceuticals
Companies developing small molecules or biologics for the treatment of different types of diseasesCompanies excluded in Biopharmaceuticals
Traditional Pharmaceutical Products, Generic DrugsTop Biopharmaceuticals Companies in Singapore
There are more than 74 companies in Biopharmaceuticals in Singapore. Hummingbird Bioscience is the top Biopharmaceuticals company in Singapore, ranked using Tracxn Score (what's this?).
Here are 5 of the top Biopharmaceuticals companies in Singapore:
Company | Description | Location | Founded | Current Stage | Private Funding Raised |
|---|---|---|---|---|---|
Developer of antibody drugs for cancer treatment | Singapore (Singapore) | 2015 | Series C | $150M | |
Targeted small molecules for cancer treatment | Singapore (Singapore) | 2010 | Public | $100M | |
Developer of gene therapies for the treatment of cardiovascular disease | Singapore (Singapore) | 2021 | Series B | $80.6M | |
Immune profiling services through their proprietary platform | Singapore (Singapore) | 2016 | Series B | $39M | |
Developer of diagnostic technologies for the detection of infectious, cancer, and neurological diseases | 2020 | Series B | $14M |
Companies founded year-on-year in the Biopharmaceuticals sector in Singapore
11 Biopharmaceuticals startups in Singapore were founded in 2020 - this is the most number of startups founded in any year in the last 10 years.
- Total Number of Companies
Year | No. of companies |
|---|---|
2026 | - |
2025 | 1 |
2024 | 1 |
2023 | 1 |
2022 | 7 |
2021 | 4 |
2020 | 11 |
2019 | 4 |
2018 | 5 |
2017 | 3 |
Stage-wise distribution of Biopharmaceuticals sector companies in Singapore
Out of the total 74 Biopharmaceuticals companies in Singapore, 38 have secured funding. Among them, 18 have reached Series A or higher, and 16 to Series B or beyond.
Founded - 74
Funded - 38
Series A+ - 18
Series B+ - 16
Series C+ - 11
Company Stage | No. of companies |
|---|---|
Founded | 74 |
Funded | 38 |
Series A+ | 18 |
Series B+ | 16 |
Series C+ | 11 |
Let us walk you through our Sectors and other offerings
Designed with precision for VCs, PE, IBs, Incubators, M&A, Innovation more
Designed with precision for VCs, PE, IBs, Incubators, M&A, Innovation more
Funding Trends in the Biopharmaceuticals sector in Singapore
Total funding year-on-year in the Biopharmaceuticals sector in Singapore
The Biopharmaceuticals sector in Singapore saw a total funding of more than $1.18B in the last 10 years. The most amount of funding was in 2022 at more than $308M.
- Total Funding
Year | Total Funding |
|---|---|
2025 | $45M |
2024 | $18.7M |
2023 | $76.7M |
2022 | $308M |
2021 | $270M |
2020 | $18M |
2019 | $56.6M |
2018 | $159M |
2017 | $80M |
Recent Funding Rounds in Biopharmaceuticals in Singapore
In the year 2025, till May 2025, Biopharmaceuticals companies in Singapore have raised $45M in equity funding across 1 round.
Here are some recent, important funding rounds in Biopharmaceuticals companies in Singapore:
Company | Round Raised | Amount Raised | Funding Date | Investors |
|---|---|---|---|---|
Series B | 2633 | May 06, 2025 | and 7 more | |
Series B | 3431 | Oct 16, 2024 | ||
Seed | 5514 | Jun 19, 2024 | ||
Series C | 5314 | Jun 10, 2024 | - | |
Seed | 1432 | Aug 10, 2023 |
_1547206285034.png?devicePixelRatio=2&height=20&width=20){kind=logo}
_1560762121774.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Top Investors in Biopharmaceuticals in Singapore
Novo Holdings is the top investor in Biopharmaceuticals companies in Singapore based on number of companies invested.
Here are some top investors in Biopharmaceuticals companies in Singapore:
Investor | Location | Top Portfolio Companies |
|---|---|---|
Hellerup (Denmark) | ||
Naarden (Netherlands) | - | |
London (United Kingdom) | - | |
London (United Kingdom) | ||
Fort Worth (United States) | - |
M&A activity in Biopharmaceuticals sector in Singapore
In the year 2022, till February 2022, 1 acquisition happened in Biopharmaceuticals sector in Singapore.
Here are some recent, important acquisitions in Biopharmaceuticals sector in Singapore:
Company | Acquisition Type | Acquisition Date | Acquirers |
|---|---|---|---|
Acqui-Hired | Feb 15, 2022 | ||
Acqui-Hired | Mar 23, 2017 | ||
Acqui-Hired | Oct 06, 2009 |
Acquisition trends in Biopharmaceuticals sector in Singapore
Here are the acquisition trends in Biopharmaceuticals sector in Singapore:
- Total Number of Acquisitions
Year | No. of companies |
|---|---|
2026 | - |
2025 | - |
2024 | - |
2023 | - |
2022 | 1 |
2021 | - |
2020 | - |
2019 | - |
2018 | - |
2017 | 1 |
IPOs in Biopharmaceuticals in Singapore
In the year 2023, till April 2023, 1 IPO happened in Biopharmaceuticals sector in Singapore.
Here are some recent, important IPOs in Biopharmaceuticals sector in Singapore:
Company | IPO Date | Exchange Symbol |
|---|---|---|
Apr 14, 2023 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Dec 06, 2019 | Frankfurt Stock Exchange (FRA) | |
Jul 22, 2015 | Singapore stock exchange. ( SGX) |
Colleges which produce the most Biopharmaceuticals companies in Singapore
Companies founded by alumni from top colleges in the Biopharmaceuticals in Singapore
Most number of Biopharmaceuticals startups in Singapore have been founded by alumni from National University of Singapore (NUS), Harvard University and University of Cambridge.
College | No. of companies |
|---|---|
National University of Singapore (NUS) | 4 |
Harvard University | 3 |
University of Cambridge | 3 |
Duke University | 2 |
INSEAD | 2 |
Nanyang Technological University (NTU) | 2 |
Cornell University | 1 |
Imperial College London | 1 |
Massachusetts Institute of Technology | 1 |
Peking University | 1 |
Total funding in Biopharmaceuticals companies founded by alumni from top colleges in Singapore
In the last 10 years, University of Cambridge graduates' Biopharmaceuticals companies in Singapore have raised the most funding among top colleges. Harvard University alumni are second, and INSEAD alumni are third.
College | Total Funding |
|---|---|
University of Cambridge | $304M |
Harvard University | $177M |
INSEAD | $163M |
Imperial College London | $163M |
Peking University | $163M |
Duke University | $94.6M |
Stanford University | $80.6M |
Cornell University | $14M |
Massachusetts Institute of Technology | $14M |
Nanyang Technological University (NTU) | $6.6M |
Top News in Biopharmaceuticals in Singapore
•
Lion TCR Achieves FDA Milestone with IND Clearance for Hepatitis B TherapyPR Newswire•Sep 15, 2025•Lion TCR
•
•
•
FDA approves global Phase 2 trial of Liocyx-M004 for HBV-related liver cancer.Vietnam Investment Review•Feb 12, 2025•Lion TCR
•
Moleac Announces PT Ferron Par Pharmaceuticals as New Exclusive Partner in IndonesiaPR Newswire•Oct 21, 2024•Moleac, Dexa Group
•
Biosyngen's BRG01 Receives FDA Approval for Phase II Clinical TrialPR Newswire•Aug 13, 2024•BioSyngen
•
SG biotech firm Lion TCR’s losses up 27% in 2023, no revenue yetShareandstocks•Aug 09, 2024•Lion TCR
•
Hummingbird Bioscience Announces Key Leadership AppointmentsBenzinga•Jul 29, 2024•Hummingbird Bioscience
•
•
